Exercise training improves diabetic renal injury by reducing fetuin-A, oxidative stress and inflammation in type 2 diabetic rats

Exercise training improves diabetic renal injury by reducing fetuin-A, oxidative stress and inflammation in type 2 diabetic rats

Background: Diabetic kidney disease (DKD) stands as a primary contributor to end-stage renal disease, associated with heightened mortality in cardiovascular diseases. This study aimed to explore the impact of an eight-week high-intensity interval training (HIIT) on renal injury in diabetic rats. Met...

Full description

Bibliographic Details
Main Authors:	Shadan Saberi, Majid Askaripour, Mohammad Khaksari, Mohammad Amin Rajizadeh, Mohammad Abbas Bejeshk, Mohammad Akhbari, Elham Jafari, Kayvan Khoramipour
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Heliyon
Subjects:	Diabetic kidney disease High-intensity interval training Inflammation Oxidative stress Fetuin-A Kim-1
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024037800

Similar Items

Fetuin A and fetuin B as an indicator of liver fibrosis in hepatitis B
by: Şenol Arzu, et al.
Published: (2023-10-01)

Evaluation of Fetuin-A level in diabetic retinopathy
by: Esraa A. M. Mostafa, et al.
Published: (2022-08-01)

Fetuin-A levels in hyperthyroidism
by: Bari&#351; Onder Pamuk, et al.
Published: (2013-01-01)

The role of intra-articular administration of Fetuin-A in post-traumatic knee osteoarthritis: an experimental study in a rat model
by: Eleni Pappa, et al.
Published: (2019-06-01)

Clinical Significance of the Fetuin-A-to-Adiponectin Ratio in Obese Children and Adolescents with Diabetes Mellitus
by: Moon-Bae Ahn, et al.
Published: (2021-12-01)

The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart
by: Teoman Dogru, et al.
Published: (2021-06-01)

Evaluation of fetuin-A, CRP, and CRP/fetuin-A values in COVID-19 patients
by: Nezahat Kurt, et al.
Published: (2022-09-01)

Detection and Characterization of Phosphorylation, Glycosylation, and Fatty Acid Bound to Fetuin A in Human Blood
by: Markéta Kovářová, et al.
Published: (2021-01-01)

SERUM FETUIN-A LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Papichev, et al.
Published: (2019-09-01)

Serum fetuin-A and RANKL levels in patients with early stage breast cancer
by: Afsar Cigdem Usul, et al.
Published: (2023-01-01)

Association of serum fetuin-B with insulin resistance and pre-diabetes in young Chinese women: evidence from a cross-sectional study and effect of liraglutide
by: Xuyun Xia, et al.
Published: (2021-08-01)

Study of The Relation between Fetuin-A and Abdominal Aorta Calcification in Chronic Hemodialysis Patients
by: Ashraf Abdelmobdy, et al.
Published: (2023-03-01)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
by: Albert Topf, et al.
Published: (2021-10-01)

A Survey on the Role of Fetuin-A in Breast Cancer: A Review
by: Robab Sheikhpour
Published: (2017-05-01)

Evaluation of the correlation between fetuin-B levels and essential hypertension: a cross-sectional study
by: Tao Gao, et al.
Published: (2023-11-01)

Liver Fetuin-A at Initiation of Insulin Resistance
by: Nicolas Lanthier, et al.
Published: (2022-10-01)

Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism
by: Oktay Bilgir, et al.
Published: (2015-02-01)

Ameliorating effect of 6-week swimming exercise on mice with experimental autoimmune encephalomyelitis (EAE) by reducing fetuin-A and increasing AMPK & NAD⁺ levels in liver tissue
by: Maryam Nazari, et al.
Published: (2022-08-01)

Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus
by: M. Yu. Gorshunska, et al.
Published: (2013-06-01)

Independent Dose–Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease
by: Chia-Wen Lu, et al.
Published: (2021-08-01)

The relationship of fetuin-a, omentin-1, and chemerin with left ventricular ejection fraction in heart failure
by: Sefa Erdi Omur, et al.
Published: (2021-01-01)

Quantitative proteomics analysis of COVID-19 patients: Fetuin-A and tetranectin as potential modulators of innate immune responses
by: Bandar Alghanem, et al.
Published: (2023-04-01)

Low Levels of Serum Fetuin-A and Retinol-Binding Protein 4 Correlate with Lipoprotein Subfractions in Morbid Obese and Lean Non-Diabetic Subjects
by: Hajnalka Lőrincz, et al.
Published: (2021-08-01)

Fetuin-A levels in association with calcific aortic valve disease: A meta-analysis
by: Muhammad Omar Larik
Published: (2023-12-01)

Effect of fetuin-A on adenine-induced chronic kidney disease model in male rats
by: Wesam Ashour, et al.
Published: (2023-05-01)

ATP releasing channels and the ameliorative effects of high intensity interval training on diabetic heart: a multifaceted analysis
by: Siyavash Joukar, et al.
Published: (2024-03-01)

Microfat exerts an anti-fibrotic effect on human hypertrophic scar via fetuin-A/ETV4 axis
by: Qian Yu, et al.
Published: (2023-03-01)

Assessment of serum fetuin-A and its gene polymorphism as a marker of insulin resistance in polycystic ovary syndrome
by: Ashraf Ali, et al.
Published: (2023-01-01)

Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers
by: Fernanda Guedes Rodrigues, et al.
Published: (2022-07-01)

Effect of High Intensity Interval Training and Portulaca Oleracea Supplement on Changes in Fetuin A Level and Insulin Resistance in Rats with Non-Alcoholic Fatty Liver Disease
by: Tahereh Khorasani-Toroghi, et al.
Published: (2022-09-01)

Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease
by: Michela Musolino, et al.
Published: (2024-02-01)

Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome
by: Karolina Kulik-Kupka, et al.
Published: (2022-09-01)

Fetuin-A: A Novel Biomarker of Bone Damage in Early Axial Spondyloarthritis. Results of an Interim Analysis of the SPACE Study
by: Marta Favero, et al.
Published: (2023-02-01)

Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms
by: Josiah Ochieng, et al.
Published: (2022-04-01)

Lung molecular and histological changes in type 2 diabetic rats and its improvement by high-intensity interval training
by: Mohammad Amin Rajizadeh, et al.
Published: (2024-01-01)

Fetuin‐A aggravates lipotoxicity in podocytes via interleukin‐1 signaling
by: Jana M. Orellana, et al.
Published: (2017-05-01)

Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?
by: Hsien-Hao Huang, et al.
Published: (2018-06-01)

Serum fetuin-a and risk of thoracic aortic aneurysms: a two-sample mendelian randomization study
by: Yang Chen, et al.
Published: (2024-02-01)

Can Fetuin A Be Utilized in the Evaluation of Elderly Patients with Acute Myocardial Infarction?
by: Raluca Tomoaia, et al.
Published: (2021-09-01)

Fetuin-A alleviates neuroinflammation against traumatic brain injury-induced microglial necroptosis by regulating Nrf-2/HO-1 pathway
by: Pengzhan Zhao, et al.
Published: (2022-11-01)